Renhe Pharmacy Co., Ltd.

Equities

000650

CNE000000NF8

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-28 pm EDT 5-day change 1st Jan Change
6.52 CNY -0.46% Intraday chart for Renhe Pharmacy Co., Ltd. -1.51% -1.66%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Renhe Pharmacy Co., Ltd. Proposes Final Cash Dividend for the Year 2023 CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Renhe Pharmacy Gets 58 Million Yuan in Government Grants MT
Tranche Update on Renhe Pharmacy Co., Ltd.'s Equity Buyback Plan announced on December 8, 2023. CI
Renhe Pharmacy Co., Ltd.'s Equity Buyback announced on December 8, 2023, has closed with 15,500,000 shares, representing 1.11% for CNY 100.01 million. CI
Tranche Update on Renhe Pharmacy Co., Ltd.'s Equity Buyback Plan announced on December 8, 2023. CI
Renhe Pharmacy Co., Ltd. announces an Equity Buyback for CNY 150 million worth of its shares. CI
Renhe Pharmacy Co., Ltd. authorizes a Buyback Plan. CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Renhe Pharmacy Co., Ltd. Announces Final Cash Dividend on A Shares for the Year 2022, Payable on 08 June 2023 CI
Renhe Pharmacy Co., Ltd. Approves Cash Dividend for 2022 CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Renhe Pharmacy Co., Ltd. Proposes Final Cash Dividend for 2022 CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Renhe Pharmacy Gets Nod Tadalafil Tablets' Registration MT
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Renhe Pharmacy Co., Ltd. Announces Final Dividend on A Shares for the Year 2021, Payable on May 27, 2022 CI
Renhe Pharmacy Co., Ltd. Approves Final Cash Dividend for 2021 CI
Renhe Pharmacy Co., Ltd. Proposes Final Cash Dividend for the Year 2021 CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Renhe Pharmacy Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Renhe Pharmacy Co., Ltd. Announces Executive Appointments CI
Chart Renhe Pharmacy Co., Ltd.
More charts
RENHE PHARMACY CO.,LTD is a China-based company principally engaged in pharmaceutical industry. The Company is mainly engaged in medical industrial manufacturing and medical merchandising. The Company’s main products include capsules, granules, tablets, powder, injections, suppositories and ointment, among others. The Company is also involved in the wholesaling and retailing of health-related products. The Company distributes its products mainly in domestic market.
More about the company
  1. Stock Market
  2. Equities
  3. 000650 Stock
  4. News Renhe Pharmacy Co., Ltd.
  5. Renhe Pharmacy Gets 58 Million Yuan in Government Grants